The association of toxicities and outcomes with circulating endothelial cells (CEC) in non-small cell lung cancer (NSCLC) patients (pts) treated with bevacizumab (Bev).

被引：0
|
作者：
Sadraei, Nooshin Hashemi
Du, Lingling
Yadav, Ruchi
Grane, Ronald
Jacobs, Barbara
Hamulak, John
Ma, Patrick C.
Pennell, Nathan A.
Elson, Paul
Borden, Ernest C.
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Cleveland Clin, Cleveland, OH USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[5] Case Comprehens Canc Ctr, Cleveland, OH USA
[6] Cleveland Clin Fdn, Dept Translat Hematol & Oncol Res, Cleveland, OH 44195 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19012
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Circulating endothelial cells as a biomarker in non-small cell lung cancer patients: correlation with clinical outcome
    Najjar, Fadi
    Alammar, Moosheer
    Bachour, Marroan
    Al-Massarani, Ghassan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2014, 29 (04): : E337 - E344
  • [32] Circulating endothelial cells and microparticles for prediction of tumor progression and outcomes in advanced non-small cell lung cancer
    Najjar, Fadi
    Alammar, Moocheer
    Al-Massarani, Ghassan
    Almalla, Nissreen
    Aljapawe, Abdulmunim
    Ikhtiar, Adnan
    CANCER BIOMARKERS, 2017, 20 (03) : 333 - 343
  • [33] ADHERENCE AND ITS ASSOCIATION WITH HEALTH OUTCOMES AMONG PATIENTS CURRENTLY TREATED FOR LEUKEMIA, MELANOMA, OR NON-SMALL CELL LUNG CANCER (NSCLC)
    Goren, A.
    DiBonaventura, M.
    Wagner, R.
    VALUE IN HEALTH, 2013, 16 (03) : A144 - A145
  • [34] Serum EGFR in patients with non-small cell lung cancer (NSCLC) treated with gefitinib
    Spreafico, A
    Gregorc, V
    Ludovini, V
    Pistola, L
    Amoroso, M
    Tofanetti, F
    Compagnoni, A
    Aondio, G
    Tonato, M
    Villa, E
    LUNG CANCER, 2005, 49 : S112 - S113
  • [35] Safety and clinical activity of MK-3475 in previously treated patients (pts) with non-small cell lung cancer (NSCLC).
    Garon, Edward B.
    Leighl, Natasha B.
    Rizvi, Naiyer A.
    Blumenschein, George R.
    Balmanoukian, Ani Sarkis
    Eder, Joseph Paul
    Goldman, Jonathan Wade
    Hui, Rina
    Soria, Jean-Charles
    Gangadhar, Tara C.
    Sun, Jong-Mu
    Patnaik, Amita
    Gubens, Matthew A.
    Lubiniecki, Gregory M.
    Zhang, Jin
    Niewood, Michelle
    Emancipator, Kenneth
    Dolled-Filhart, Marisa
    Hanson, Mary Elizabeth
    Gandhi, Leena
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Response and survival in African American (AA) patients (pts) with non-small cell lung cancer (NSCLC) treated with erlotinib (E)
    Villaflor, V. M.
    Kanteti, R.
    Watson, S. M.
    Karrison, T.
    Vokes, E. E.
    Salgia, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Characterisation of Circulating Immune Cells in a Cohort of Non-small Cell Lung Cancer Patients Treated with Immunotherapy
    Gascon-Ruiz, M.
    Pardo, J.
    Cruellas, M.
    Esteban, P.
    Galvez, E. M.
    Lastra, R.
    Martinez-Lostao, L.
    Ocariz, M.
    Pano, J. R.
    Quilez, E.
    Ramirez, A.
    Sesma, A.
    Torres-Ramon, I.
    Yubero, A.
    Zapata, M.
    Isla, D.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S561 - S561
  • [38] Cobolimab With Dostarlimab and Docetaxel in Patients (pts) With Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
    Kim, Hye Ryun
    Gridelli, Cesare
    Kapur, Dinesh
    Tufman, Amanda
    Felip, Enriqueta
    Velcheti, Vamsidhar
    Kim, Yu Jung
    Goetze, Thorsten
    Lopez, Pilar Garrido
    Corre, Romain
    Penkov, Konstantin
    Anjum, Rana
    Di Pace, Brian
    Liu, Wenlei
    Borgovan, Theo
    Ledger, Danielle
    Carver, Jennifer
    Waszak, Angela
    Dhar, Arindam
    Novello, Silvia
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 163 - 163
  • [39] Predictive value of KRAS mutations in advanced non-small cell lung cancer (NSCLC) patients (pts) treated with chemotherapy (CT)
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    Derks, Jules
    Mellema, Wouter
    Heideman, Danielle
    Van Suylen, Robertjan
    Thunnissen, Erik
    CANCER RESEARCH, 2011, 71
  • [40] Effectiveness of Bevacizumab (BV) Maintenance in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Treated in US Community Practices
    Thomas, S.
    Ravelo, A.
    Yu, E.
    Dranitsaris, G.
    Kalberer, T.
    Beegle, N.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S618 - S618
12345